These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14117127)

  • 1. A SIMPLE QUANTITATIVE METHOD FOR THE INVESTIGATION OF THE INHIBITING ACTION OF CYTOSTATICS ON SUCCINATE DEHYDROGENASE.
    DOMBRADI GA
    Enzymologia; 1964 Feb; 26():321-8. PubMed ID: 14117127
    [No Abstract]   [Full Text] [Related]  

  • 2. [STUDIES ON THE SUCCINOTRANSHYDROGENASE-INHIBITING CAPACITY OF CYTOSTATICS].
    DOMBRADI G
    Kiserl Orvostud; 1963 Oct; 15():503-7. PubMed ID: 14092925
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE REDUCTION OF RADIOPHOSPHORUS 32 INCORPORATION INTO CANCER CELLS BY NONTOXIC DOSES OF CYTOSTATIC SUBSTANCES].
    KREPSZ I; PUPP A; GYERGYAY F
    Radiobiol Radiother (Berl); 1963; 4():479-82. PubMed ID: 14120270
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE EFFECT OF ALKYLATING CYTOSTATICS ON THE NUCLEIC ACID METABOLISM OF EHRLICH ASCITES TUMOR CELLS].
    LISS E; PALME G
    Z Krebsforsch; 1964 Jul; 66():196-206. PubMed ID: 14256642
    [No Abstract]   [Full Text] [Related]  

  • 5. [ON A METHOD FOR EVALUATING CARCINOSTATIC AGENTS].
    KONDO T; ICHIHASHI H; IMAMURA T; OHKUBO K
    Gan No Rinsho; 1964 Jan; 10():17-21. PubMed ID: 14150014
    [No Abstract]   [Full Text] [Related]  

  • 6. ACTION OF A NEW SARCOMYCIN DERIVATIVE ON MITOCHONDRIAL ENZYMES OF EHRLICH MOUSE ASCITES CELLS.
    ROCCA E; BRUNORI M
    Biochem Pharmacol; 1964 Mar; 13():379-84. PubMed ID: 14157598
    [No Abstract]   [Full Text] [Related]  

  • 7. [EXPERIMENTAL REGIONAL PERFUSION OF THE EXTREMITIES WITH CYTOSTATICS].
    HUSVETI S; BESZNYAK I; KUDASZ J
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963 Nov; 304():722-5. PubMed ID: 14120191
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphological and enzymatic changes in a mouse ascites lymphoma with induced resistance].
    GATI E
    Z Krebsforsch; 1963; 65():506-12. PubMed ID: 13946781
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECT OF HEPARIN-BOUND ALKYLATING AGENTS AND ENZYME INHIBITORS ON NEOPLASTIC GROWTH.
    CSABA G; KOROESI J; HORVATH C; MOLD K; ACS T
    Neoplasma; 1964; 11():137-44. PubMed ID: 14160693
    [No Abstract]   [Full Text] [Related]  

  • 10. The analysis of changes in the activation energy of succinate dehdrogenase as influenced by some antitumour agents.
    Dombradi GA; Csányi I; Domján G
    Biochem Pharmacol; 1966 Apr; 15(4):508-11. PubMed ID: 5954983
    [No Abstract]   [Full Text] [Related]  

  • 11. IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. II. CORRELATION OF IN VITRO INHIBITION OF DEHYDROGENASE AND GROWTH WITH IN VIVO INHIBITION OF EHRLICH ASCITES TUMOR.
    DIPAOLO JA
    Proc Soc Exp Biol Med; 1963 Nov; 114():384-7. PubMed ID: 14101198
    [No Abstract]   [Full Text] [Related]  

  • 12. [MODIFICATIONS OF THE GLYCOLYTIC PROCESS OF THE SARCOMATOUS CELL UNDER THE INFLUENCE OF TRYPANOSOMA CRUZI EXTRACTS].
    COUDERT J; MICHEL-BRUN J
    C R Seances Soc Biol Fil; 1964; 158():68-71. PubMed ID: 14145455
    [No Abstract]   [Full Text] [Related]  

  • 13. THE INHIBITORY ACTION OF PHENYLBUTAZON ON THE SUCCINOXIDASE ACTIVITY OF RAT TISSUE HOMOGENATES.
    GOEROEG P; SZPORNY L
    Biochem Pharmacol; 1963 Sep; 12():1017-21. PubMed ID: 14068497
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON THE CARCINOSTATIC EFFECTS OF AMINOALKYLATING COMPOUNDS. 1. ON CYTOSTATICS].
    SCHOENENBERGER H; ADAM A
    Arzneimittelforschung; 1964 Oct; 14():1168. PubMed ID: 14343486
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE MORPHOLOGICAL EFFECT OF DIFFERENT CHEMOTHERAPEUTIC AGENTS ON DEGRANOL-SENSITIVE AND DEGRANOL-RESISTANT NK/LY ASCITES TUMOR].
    GATI E
    Z Krebsforsch; 1965 Feb; 66():460-5. PubMed ID: 14263006
    [No Abstract]   [Full Text] [Related]  

  • 16. THE ADVERSE EFFECTS OF CANCER CHEMOTHERAPY.
    KONDO T
    Acta Unio Int Contra Cancrum; 1964; 20():194-8. PubMed ID: 14151882
    [No Abstract]   [Full Text] [Related]  

  • 17. THE EFFECT OF PHENAZINE METHOSULPHATE, PYOCYANINE AND EDTA ON MITOCHONDRIAL SUCCINIC DEHYDROGENASE.
    HARMAN JW; MACBRINN MC
    Biochem Pharmacol; 1963 Nov; 12():1265-78. PubMed ID: 14078915
    [No Abstract]   [Full Text] [Related]  

  • 18. [CONTRIBUTION TO THE EXPERIMENTAL STUDY OF THE HEPATIC SUCCINOXIDASE SYSTEM AND ITS CORRELATIONS WITH BILIARY SECRETION, AFTER ADMINISTRATION OF ENERGETIC ENZYMATIC INHIBITORS].
    ZAMFIRESCU-GHEORGHIU M; GEORGESCU M; VELICAN D; RUNCAN V
    Stud Cercet Med Interna; 1963; 123():827-35. PubMed ID: 14107490
    [No Abstract]   [Full Text] [Related]  

  • 19. INFLUENCES OF ANTICANCER AGENTS ON THE METABOLISM OF DELTA-AMINOLEVULINIC ACID IN MORMAL AND TUMOR-BEARING MICE.
    HANO K; AKASHI A
    Gan; 1964 Feb; 55():25-40. PubMed ID: 14133995
    [No Abstract]   [Full Text] [Related]  

  • 20. DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE.
    BERENBAUM MC; BROWN IN
    Immunology; 1964 Jan; 7(1):65-71. PubMed ID: 14113077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.